What one share of Compugen holds
We are a clinical-stage therapeutic discovery and development company utilizing Unigen™, our AI/ML powered computational discovery platform, to identify novel drug targets and to develop therapeutics in the field of cancer immunotherapy.
Compugen’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.78 |
|---|---|
| Profit | $0.38 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.33 |
| Cash and investments | $1.06 |
| Book value | $1.09 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $0.01 | −$0.13 | $0.00 | −$0.25 | — | $0.83 |
| 2010 | $0.03 | −$0.22 | $0.00 | −$0.13 | — | $0.83 |
| 2011 | — | −$0.35 | $0.00 | −$0.27 | — | $0.56 |
| 2012 | $0.01 | −$0.38 | $0.03 | −$0.33 | — | $0.48 |
| 2013 | $0.09 | −$0.36 | $0.01 | −$0.17 | — | $0.78 |
| 2014 | $0.26 | −$0.26 | $0.04 | −$0.27 | — | $2.11 |
| 2015 | $0.18 | −$0.40 | $0.06 | −$0.57 | — | $1.78 |
| 2016 | $0.01 | −$0.62 | $0.05 | −$0.44 | — | $1.24 |
| 2017 | — | −$0.72 | $0.01 | −$0.61 | — | $0.57 |
| 2018 | $0.32 | −$0.41 | $0.00 | −$0.24 | — | $0.62 |
| 2019 | — | −$0.43 | $0.00 | −$0.44 | — | $0.56 |
| 2020 | $0.03 | −$0.37 | $0.00 | −$0.36 | — | $1.43 |
| 2021 | $0.07 | −$0.41 | $0.00 | −$0.27 | — | $1.23 |
| 2022 | $0.09 | −$0.39 | $0.01 | −$0.40 | — | $0.90 |
| 2023 | $0.38 | −$0.21 | $0.00 | −$0.41 | — | $0.73 |
| 2024 | $0.31 | −$0.16 | $0.00 | $0.55 | — | $0.61 |
| 2025 | $0.78 | $0.38 | $0.00 | $0.33 | — | $1.09 |
Common questions about Compugen
How much does one share of Compugen earn?
Over its latest fiscal year, each share of Compugen earned $0.38 of profit on $0.78 of sales, keeping about 49¢ of every $1 (profit margin).
Does Compugen pay a dividend?
Compugen didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Compugen’s book value per share?
Compugen’s book value is $1.09 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Compugen have?
Each share of Compugen has $1.06 of cash and investments, as of December 31, 2025.
What is Compugen’s free cash flow per share?
$0.33 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Compugen bought back shares?
Compugen’s share count rose about 218% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.